Under ISO 13485:2016 clause 4.2.2, every medical device manufacturer must maintain a quality manual that defines the scope of the QMS, documents or references the procedures that support it, and describes how QMS processes interact with each other. Where a manufacturer legitimately excludes a clause of the standard, that exclusion and its justification must appear in the quality manual. The FDA Quality System Regulation successor, the Quality Management System Regulation (QMSR, 21 CFR Part 820, effective 2026), aligns closely with ISO 13485 and carries similar documentation expectations, making the quality manual a dual-purpose document for manufacturers selling into both the US and international markets.
The quality manual is a navigation document, not a procedures library. Its purpose is to show how the QMS holds together as a system, not to reproduce the detailed how-to content that belongs in SOPs, work instructions, and forms. A quality manual that replicates procedure-level detail becomes too large to serve its structural role and too brittle to maintain. Conversely, a manual that is too sparse leaves auditors without a clear map of process interactions and can trigger a finding on its own terms.
During a regulatory audit, inspectors and notified body auditors typically open with the quality manual. It sets the scope of the audit, identifies which clauses apply, and signals how documented procedures are organized. A manual that describes an idealized system diverging from actual practice is one of the most common audit liabilities: the gap between the written system and the real one becomes evidence of systemic nonconformance. Equally problematic are manuals written at certification time and not revisited, leaving them misaligned with process changes, organizational restructuring, or updated regulatory requirements.
The whitepaper below walks through how qmsWrapper structures and maintains a living quality manual that stays current with your documented procedures and audit-ready at all times.
